The two organizations will partner to foster healthy habits in young children and their families by offering free resources and videos and “Sesamatized” spaces.

NewYork-Presbyterian, one of the nation’s leading healthcare systems, is partnering with Van Leeuwen Ice Cream to increase blood donations in New York City by making the experience of donating blood a little sweeter.

New ambulatory care center expands access to world-class spine care from Columbia and Weill Cornell Medicine and provides a seamless patient experience

The new unit provides exceptional, personalized care from Columbia physicians for pregnant women and their newborns in Westchester County.

Tirzepatide, a new injectable weight-loss drug with the trade name Zepbound, reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three-year period, compared with placebo, according to the results of a new study led by investigators at Weill Cornell Medicine, NewYork-Presbyterian, Yale School of Medicine and other institutions.

Severe COVID-19 arises in part from the SARS-CoV-2 virus’s impact on mitochondria, tiny oxygen-burning power plants in cells, which can help trigger a cascade of organ- and immune system-damaging events, suggests a study by investigators at Weill Cornell Medicine, Johns Hopkins Medicine, Children’s Hospital of Philadelphia, and the University of Pittsburgh in collaboration with other institutions.

The Transcatheter Cardiovascular Therapeutics (TCT) conference has long been one of the top educational forums in interventional cardiovascular medicine.

Dr. Chani Traube, the Gerald M. Loughlin, MD Professor of Pediatrics at Weill Cornell Medicine, has been awarded a $3.4 million grant, with the possibility of extending to a total of $17 million over five years, from the National Institutes of Health, for a large-scale clinical trial called Optimizing Pain Treatment in Children on Mechanical ventilation (OPTICOM).